title: Daclatasvir plasma concentration assessment in HIV-HCV-coinfected real-life patients.
authors.affiliation: AP-HM Hôpital de la Timone, Service de Pharmacocinétique et Toxicologie, Marseille, France.
authors.forename: Audrey
authors.initials: A
authors.lastname: Taton
authors.affiliation: IHU Méditerranée Infection, Aix Marseille Université, AP-HM Hôpital de la Timone, Fédération de Bactériologie-Virologie-Hygiène, URMITE UM 63 CNRS 7278 IRD 198 INSERM 1095, Marseille, France.
authors.forename: Philippe
authors.initials: P
authors.lastname: Colson
authors.affiliation: Aix Marseille Université, AP-HM Hôpital de La Conception, Service de Maladies Infectieuses, Marseille, France.
authors.forename: Catherine
authors.initials: C
authors.lastname: Dhiver
authors.affiliation: AP-HM Centre Pénitentiaire de Marseille, Hôpitaux Sud, Service de Médecine en Milieu Pénitentiaire, Marseille, France.
authors.forename: Jean-Marie
authors.initials: JM
authors.lastname: Ruiz
authors.affiliation: AP-HM Hôpital Sainte Marguerite, Service d'Immuno-Hématologie Clinique, Marseille, France.
authors.forename: Sylvie
authors.initials: S
authors.lastname: Bregigeon
authors.affiliation: Aix Marseille Université, AP-HM Hôpital de La Conception, Service de Maladies Infectieuses, Marseille, France.
authors.forename: Christelle
authors.initials: C
authors.lastname: Tomei
authors.affiliation: AP-HM Hôpital de La Timone, Service d'Hépato-gastro-entérologie, Marseille, France.
authors.forename: Emmanuelle
authors.initials: E
authors.lastname: Ressiot
authors.affiliation: Aix Marseille Université, AP-HM Hôpital de La Conception, Service de Maladies Infectieuses, Marseille, France.
authors.forename: Amélie
authors.initials: A
authors.lastname: Menard
authors.affiliation: Aix Marseille Université, AP-HM Hôpital Sainte Marguerite, Service d'Immuno-Hématologie Clinique, INSERM U912 SESSTIM, Marseille, France.
authors.forename: Isabelle
authors.initials: I
authors.lastname: Poizot-Martin
authors.affiliation: Aix Marseille Université, AP-HM Hôpital de La Conception, Service de Maladies Infectieuses, Marseille, France.
authors.forename: Isabelle
authors.initials: I
authors.lastname: Ravaux
authors.affiliation: Aix Marseille Université, AP-HM Hôpital de la Timone, Service de Pharmacocinétique et Toxicologie, CRO2 INSERM U911, Marseille, France.
authors.forename: Bruno
authors.initials: B
authors.lastname: Lacarelle
authors.affiliation: Aix Marseille Université, AP-HM Hôpital de la Timone, Service de Pharmacocinétique et Toxicologie, CRO2 INSERM U911, Marseille, France.
authors.forename: Caroline
authors.initials: C
authors.lastname: Solas
mesh_terms: D000998:Antiviral Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use; D002219:Carbamates; D060085:Coinfection / Q000188:drug therapy* / Q000821:virology; D005838:Genotype; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000821:virology; D016174:Hepacivirus / Q000235:genetics; D006526:Hepatitis C / Q000175:diagnosis / Q000188:drug therapy* / Q000821:virology; D019698:Hepatitis C, Chronic / Q000188:drug therapy / Q000821:virology; D006801:Humans; D007093:Imidazoles / Q000493:pharmacokinetics* / Q000627:therapeutic use; D011759:Pyrrolidines; D016896:Treatment Outcome; D014633:Valine / Q000031:analogs & derivatives; D019562:Viral Load
chemical_list: D000998:Antiviral Agents; D002219:Carbamates; D007093:Imidazoles; D011759:Pyrrolidines; D014633:Valine; C549273:daclatasvir